Immunovia AB (publ) (IMMVF)
USD 0.07
(0.0%)
USD 0.07
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -72.5 Million SEK | -5.89% |
| 2022 | -68.46 Million SEK | 73.06% |
| 2021 | -254.14 Million SEK | 41.62% |
| 2020 | -435.33 Million SEK | -93.24% |
| 2019 | -225.27 Million SEK | 41.66% |
| 2018 | -386.13 Million SEK | -100.67% |
| 2017 | -192.42 Million SEK | 25.73% |
| 2016 | -259.09 Million SEK | -241.96% |
| 2015 | -75.76 Million SEK | -138.23% |
| 2014 | -31.8 Million SEK | -781.8% |
| 2013 | -3.6 Million SEK | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -42.38 Million SEK | 41.54% |
| 2024 Q2 | -28.04 Million SEK | 13.28% |
| 2023 Q3 | -80.38 Million SEK | 30.65% |
| 2023 FY | -72.5 Million SEK | -5.89% |
| 2023 Q2 | -115.92 Million SEK | -258.89% |
| 2023 Q1 | -32.3 Million SEK | 52.82% |
| 2023 Q4 | -72.5 Million SEK | 9.81% |
| 2022 Q3 | -118.97 Million SEK | 24.25% |
| 2022 FY | -68.46 Million SEK | 73.06% |
| 2022 Q1 | -199.04 Million SEK | 21.68% |
| 2022 Q2 | -157.06 Million SEK | 21.09% |
| 2022 Q4 | -68.46 Million SEK | 42.45% |
| 2021 Q1 | -387.84 Million SEK | 10.91% |
| 2021 FY | -254.14 Million SEK | 41.62% |
| 2021 Q4 | -254.14 Million SEK | 16.57% |
| 2021 Q3 | -304.63 Million SEK | 11.83% |
| 2021 Q2 | -345.51 Million SEK | 10.91% |
| 2020 Q3 | -476.21 Million SEK | 8.53% |
| 2020 Q1 | -186.06 Million SEK | 17.41% |
| 2020 Q4 | -435.33 Million SEK | 8.59% |
| 2020 FY | -435.33 Million SEK | -93.24% |
| 2020 Q2 | -520.61 Million SEK | -179.8% |
| 2019 Q1 | -325.63 Million SEK | 15.67% |
| 2019 Q4 | -225.27 Million SEK | 13.09% |
| 2019 Q2 | -294.12 Million SEK | 9.68% |
| 2019 FY | -225.27 Million SEK | 41.66% |
| 2019 Q3 | -259.2 Million SEK | 11.87% |
| 2018 Q4 | -386.13 Million SEK | 7.09% |
| 2018 FY | -386.13 Million SEK | -100.67% |
| 2018 Q3 | -415.6 Million SEK | 7.07% |
| 2018 Q1 | -167.79 Million SEK | 12.8% |
| 2018 Q2 | -447.21 Million SEK | -166.53% |
| 2017 Q2 | -228.32 Million SEK | 7.32% |
| 2017 FY | -192.42 Million SEK | 25.73% |
| 2017 Q4 | -192.42 Million SEK | 10.62% |
| 2017 Q3 | -215.3 Million SEK | 5.71% |
| 2017 Q1 | -246.36 Million SEK | 4.91% |
| 2016 Q2 | -59.72 Million SEK | -178.83% |
| 2016 FY | -259.09 Million SEK | -241.96% |
| 2016 Q1 | 75.76 Million SEK | 200.0% |
| 2016 Q4 | -259.09 Million SEK | 0.0% |
| 2015 Q1 | -22.76 Million SEK | 28.43% |
| 2015 Q2 | -22.76 Million SEK | 0.0% |
| 2015 Q4 | -75.76 Million SEK | 0.0% |
| 2015 Q3 | -75.76 Million SEK | -232.88% |
| 2015 FY | -75.76 Million SEK | -138.23% |
| 2014 Q1 | 3.6 Million SEK | 0.0% |
| 2014 Q4 | -31.8 Million SEK | 0.0% |
| 2014 Q3 | -31.8 Million SEK | 0.0% |
| 2014 FY | -31.8 Million SEK | -781.8% |
| 2013 FY | -3.6 Million SEK | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| American Bio Medica Corporation | 2.2 Million USD | 3386.582% |
| Arrayit Corporation | 1.05 Million USD | 6968.451% |
| Atlantic International Corp. | 236.49 Thousand USD | 30756.755% |
| Biocept, Inc. | -788 Thousand USD | -9100.761% |
| Bioqual, Inc. | -12 Million USD | -503.826% |
| CardioGenics Holdings Inc | 22.73 Thousand USD | 318944.276% |
| DermTech, Inc. | 17.65 Million USD | 510.706% |
| Global WholeHealth Partners Corporation | - USD | Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | -572.49 Million USD | 87.336% |
| HTG Molecular Diagnostics, Inc. | -7.37 Million USD | -882.824% |
| iMD Companies, Inc. | 1.11 Million USD | 6597.096% |
| IDenta Corp. | 524.85 Thousand USD | 13913.799% |
| Interpace Biosciences, Inc. | 7.69 Million USD | 1042.319% |
| Integrative Health Technologies, Inc. | -26.95 Thousand USD | -268904.156% |
| InVitro International | -313.14 Thousand USD | -23053.074% |
| Lumos Diagnostics Holdings Limited | 1.56 Million USD | 4730.012% |
| Many Bright Ideas Technologies Inc. | -713.00 USD | -10168483.45% |
| Medical Imaging Corp. | 3.79 Million USD | 2012.51% |
| NovelStem International Corp. | 3.52 Million USD | 2158.818% |
| Optigenex Inc. | 8.93 Million USD | 911.531% |
| PharmChem, Inc. | -1.49 Million USD | -4751.537% |
| Proteome Sciences plc | 14.57 Million USD | 597.499% |
| Response Genetics, Inc | -13.08 Million USD | -454.042% |
| Rennova Health, Inc. | 14.82 Million USD | 588.891% |
| RushNet, Inc. | 4.8 Million USD | 1610.192% |
| ScreenPro Security Inc. | 135.58 Thousand USD | 53571.889% |
| Stella Diagnostics Inc. | 6.19 Million USD | 1270.698% |
| StageZero Life Sciences Ltd. | 1.78 Million USD | 4163.105% |
| Todos Medical Ltd. | 38.31 Million USD | 289.231% |